Breaking News
July 18, 2018 - Hunger hormones could be key to new treatments for drug, alcohol addiction
July 18, 2018 - Nitrate-cured meats may contribute to mania, study finds
July 18, 2018 - Why men may recover more quickly from influenza infections than women
July 18, 2018 - KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
July 18, 2018 - Self-control and obesity: Gender matters in children
July 18, 2018 - Bioengineers, diabetes researchers convene to discuss future concepts for precision medicine
July 18, 2018 - Practicing yoga benefits pregnant women, study suggests
July 18, 2018 - FDA Approves Symtuza (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
July 18, 2018 - Deep data dive helps predict cerebral palsy
July 18, 2018 - Stricter firearm legislation associated with reduced murder and suicide rates
July 18, 2018 - Physical and sexual abuse in childhood associated with endometriosis risk
July 18, 2018 - Omega 3 supplements do not reduce risk of heart disease, stroke or death
July 18, 2018 - GSA’s new publication provides support for safe use of OTC analgesics by older adults
July 18, 2018 - Researchers receive grant from U.S. Department of Education to study children with HFASD
July 18, 2018 - Early childhood adversity increases sensitivity of the body’s immune response to cocaine
July 18, 2018 - Parental incarceration affects health behaviors of children in adulthood
July 18, 2018 - Researchers find that yellow fever and Asian tiger mosquitoes can carry new virus
July 18, 2018 - Two Regimens Fail to Stop Declines in β-Cell Function
July 18, 2018 - Researchers apply computing power to track the spread of cancer
July 18, 2018 - Olfactory receptors play pathophysiological role in all organs than merely smell perception
July 18, 2018 - Fish consumption associated with lower risk of early death
July 18, 2018 - MR Solutions’ 7T MRI imaging system installed at University of Hawaii
July 18, 2018 - Humorous ads screened around World Cup game achieve higher biometric response than sporty ads
July 18, 2018 - New study demonstrates little effect of hormone therapy on artery thickness
July 18, 2018 - A 3-Pronged Plan to Cut Type 2 Diabetes Risk
July 18, 2018 - New clues to sepsis may speed diagnosis
July 18, 2018 - Stars of Stanford Medicine: Improving cardiovascular health in Africa and beyond
July 18, 2018 - Heart attack risk continues to increase among pregnant women, study finds
July 18, 2018 - Few tips to help avoid sunburns in summer
July 18, 2018 - High-fat diet and systemic inflammation contribute to progression of prostate cancer
July 18, 2018 - Researchers develop 3D map of gene interactions that play key role in heart disease
July 18, 2018 - Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery
July 18, 2018 - Report warns of dog illness that can spread to owners
July 18, 2018 - A winning essayist’s tips for keeping track of scientific facts
July 18, 2018 - Researchers seek to understand role of APOE mutation in Alzheimer’s disease
July 18, 2018 - Animal studies reveal brain changes responsible for appetite effects of cannabis
July 18, 2018 - New ZEISS ZEN Intellesis machine allows segmentation of correlative microscopy
July 18, 2018 - Study findings highlight importance of early detection of SMA through newborn screening
July 18, 2018 - Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
July 18, 2018 - Diabetes researchers find switch for fatty liver disease
July 18, 2018 - The future of the microbiome: A conversation
July 18, 2018 - States attacking ACA would hurt most if shield on preexisting conditions were axed
July 18, 2018 - Novel delivery system for bacteriophages could offer new way to battle lung infections
July 18, 2018 - PTSD may increase risk of stroke, heart attack in World Trade Center response crews
July 18, 2018 - Finding the right protective eyewear for young athletes
July 18, 2018 - Routine screening, treatment could help stem nationwide opioid epidemic
July 17, 2018 - AI and radar technologies could help diabetics manage their disease
July 17, 2018 - New Stanford algorithm could improve diagnosis of many rare genetic diseases
July 17, 2018 - Burdensome symptoms of eczema can lead to impaired quality of life, shows study
July 17, 2018 - Sartorius Stedim Biotech and Penn State partner to advance teaching, research in biotechnology
July 17, 2018 - Researchers map family trees of cancer cells to understand how AML responds to new drug
July 17, 2018 - Mortality from heart failure remains higher in women than men
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Large international study finds new risk genes for hay fever
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Most older adults with probable dementia found to be either undiagnosed or unaware of it
July 17, 2018 - Vallum receives FDA clearance to market PEEK spinal interbody fusion device
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
Defining the biology of autism

Defining the biology of autism

image_pdfDownload PDFimage_print

When approaching faculty to gauge interest in a new Feinberg center focusing on autism, Peter Penzes, Ph.D., Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences, received puzzled responses from some professors and scientists.

“It turns out there are a range of scientists and labs at Northwestern studying various aspects of autism and its development at a basic science level or a clinical level—but many of them didn’t know about each other.”

Penzes hopes those days are in the past with the launch of the new Center for Autism and Neurodevelopment (CAN), a translational science hub that aims to investigate the neurobiology of autism and facilitate the development of new treatments.

Penzes, as director of the center, recruited 28 scientists from basic science, translational and clinical specialties—a bottom-up approach that will both foster collaboration and train the next generation of scientists in the fields of autism and neurodevelopment.

In addition, CAN will host nationally renowned speakers in a monthly seminar series, to inform Northwestern and the larger community about the latest in autism research across the globe.

“This center is the glue that will bring all these people together,” Penzes said.

A Blank Slate

In comparison to other neurological diseases such as Parkinson’s disease or Alzheimer’s disease, the neurobiology of autism is relatively unstudied, according to Penzes.

“Up until ten years ago, all we knew about autism was based on symptoms displayed by patients,” Penzes said.

Today, advances in genomic sequencing technology and the realization that autism is much more common than previously thought—now estimated at one in 68 children—have placed the genetic component of autism at the forefront.

However, even with strong efforts over the past five years, the specific genetic mechanisms remain opaque, according to Penzes. Some children’s autism may be traced back to a single gene, but those cases are rare—more common are hundreds of small gene variations that cumulatively result in an autism spectrum disorder, making it difficult to zero in on the genes that lead to specific neurophysiological changes.

In addition, there’s no established biomarker for autism, further complicating investigations. While diseases such as Parkinson’s or Alzheimer’s have protein deposits that can indicate disease, there’s no objective measure of autism, according to Penzes, making it difficult to determine if a treatment is working, for example.

CAN hopes to build personalized treatments from the ground up, grouping together patients with similar genetic mutations, identifying the exact time and place where normal brain development is diverted off course and developing drugs to treat those biological changes.

Western Blots to Pills and Shots

While identifying groups of patients with similar mutations may sound simple, about 1,000 genes have been linked with autism so far, and that number is only growing. Narrowing the pool by studying conditions linked to autism but with a more homogenous genetic cause is a strategy used by some scientists, including Anis Contractor, Ph.D., professor of Physiology.

Contractor studies fragile X syndrome (FXS), a genetic disorder in which about half of all patients are also diagnosed with autism—making it the single largest monogenic (linked to a mutation in a single gene) cause of autism in the United States. While most genetic mutations that cause autism are rare, patients with FXS have the mutations in a single gene on the X chromosome, so FXS can be used as a laboratory model for certain aspects of autism, including sensory hypersensitivity.

“A lot of patients don’t like loud sounds or don’t like to be touched,” Contractor said. “When I talk to parents of children with autism, some tell me these sensory issues lead to many other problems, because the kids are withdrawn or socially isolated.”

The exact neurobiology behind this symptom is unknown, so Contractor tracked the development of the sensory cortex in mouse models of FXS, finding there were several “critical periods” of synapse formation that were delayed in the mouse model of the disorder.

“The timing of these critical periods has to be perfect—if you mistime them, the whole system doesn’t wire properly,” Contractor said. “In the FXS mouse, the sensory response from the whiskers excites more neurons in the cortex than it should; we think that is partially responsible for the hypersensitivity symptoms.”

Digging deeper, Contractor traced the critical period shift to an imbalance of intracellular chloride. He said a drug originally approved for hypertension could possibly be used to correct the critical period shift, due to its action on chloride transporters in developing neurons.

“They’ve actually conducted clinical trials of this drug in France and given it to children with autism,” Contractor said. “While it was a small population and the drug’s not perfect, it improved behavioral scores significantly.”

Through the Looking Glass

Genetics aren’t the only starting point for the translational pipeline—imaging will also have a role to play at CAN, according to John Csernansky, Ph.D., chair of Psychiatry and Behavioral Sciences.

“Using imaging to better understand brain function in subjects with autism may help us to identify the precise brain circuits that are affected by the disorder, which could lead to new interventions such as drugs or behavioral therapies,” said Csernansky, also the Lizzie Gilman Professor of Psychiatry and Behavioral Sciences. “The new center will help us identify new collaborators and start new projects.”

Techniques are available that can help autistic patients ease into studies that include imaging, according to Csernansky.

“Patients with autism can be uncomfortable being confined in closed spaces, such as the MR scanner,” Csernansky said. “However, individuals with autism can become more comfortable with the MR scanner by having them spend time in a ‘mock’ scanner, which simulates the space and noise of the MR scanner.”

Ahead of the Pack

The field of autism neurobiology is ripe for discovery: It’s historically understudied and new technology now allows scientists to quickly and cheaply sequence a patient’s genome or grow models of a patient’s brain and test therapies.

While other institutions may have some form of autism research initiative, CAN is unique for its singular focus on translational science, according to Penzes.

“Most autism centers are doing only patient care,” Penzes said. “There are very few places where you have 28 scientists from across disciplines that are brought together with the unifying goal of understanding the neurobiology of autism.”

“If there are new drugs for autism, this is where they are going to come from,” Penzes added.


Explore further:
When kids’ autistic brains can’t calm down

Provided by:
Northwestern University

Tagged with:

About author

Related Articles